Global Angiongenesis Inhibitors and Stimulators Industry Market Research 2022-2030

  • Product Code:
  • Published Date:
    21 Oct 2022
  • Region:
  • Pages:
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.



The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.

With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.

Market Overview:

Translate Report

"Angiogenesis is the physiological process of forming new blood vessels from existing ones. Angiogenesis is generally divided into two types: vegetative angiogenesis and neovascularization. Angiogenesis is the basic mechanism of angiogenesis in which the formation of new blood vessels is controlled in successive steps. Angiogenesis is a disease in which existing blood vessels divide to form new blood vessels (also called mitotic angiogenesis). Unlike angiogenesis, co-development does not require local proliferation of endothelial cells. Angiogenesis is mainly associated with various diseases such as age-related macular degeneration, rheumatoid arthritis, cancer, and psoriasis. Blood vessels stimulated by angiogenesis. 

Avastin (bevacizumab), Griuk, Tarture and Ilsa are the most important angiogenesis inhibitors in the world. The increase in cancer cases during the forecast period will drive the growth of this market as research and development activities for the production of new angiogenic drugs for cancer treatment are at a top level. 
According to the World Health Organization (WHO), an estimated 8.2 million people died from cancer in 2012. The annual incidence of cancer is projected to increase from 14 million to 22 million per year over the next 20 years. 


Additionally, the National Cancer Institute reported approximately 1,660,290 cases in the United States in 2013 and said technological advances will drive the growth of the angiogenesis inhibitors and inducers market. Thus, angiogenesis studies have enabled the identification of various vascular agonists and antagonists. However, the high cost of these drugs limits the growth of this market.

Geographically, North America is the largest market for angiogenesis inhibitors and stimulants, followed by Europe, because of the large patient base in these regions and the increasing population seeking treatment. The market for angiogenesis inhibitors and stimulants in Asia-Pacific countries such as India and China, and Southeast Asian countries is growing strongly because the total number of newly diagnosed cancer patients in the region has increased. According to the World Health Organization, 60% of the total annual global cancer cases occur in Africa, Asia and South America.


Some of the major players in the angiogenesis inhibitor and stimulant market are Abbott Laboratories, Adnexus Therapeutics, Inc., F. Hoffman-La Roche, Ltd., Genentech, Inc., Amgen, Inc., AstraZeneca Plc., Novartis AG, Pfizer., Inc., Chugai Pharmaceutical Co., Ltd., EntreMed, Inc. and Eyetech, Inc. Our main support is the four-quadrant framework EIRS, which provides detailed four-element visualization: Customer experience map Data-based research information and tools Actionable results that meet all business priorities Strategic framework for driving customer journey growth1. 


Customer Experience Map This study provides an in-depth evaluation of various customer journeys related to the market and its market segments. It provides various customer impressions of products and services used. This analysis will carefully study your pain points and fears at various points in contact with customers. Consulting and business intelligence solutions will help stakeholders, including CXO, define a customer experience map that suits their needs.


This will help them aim to drive customer interaction with their brand. Insights and tools Various insights into research are based on a careful cycle of primary and secondary research that analysts participate in during the investigation process. Analysts and consultants use quantitative customer knowledge tools and industry-wide market forecasting methods to provide results and make them reliable. The research not only provided estimates and forecasts, but also cleverly evaluated these numbers about market dynamics. These insights combine a data-driven research framework with qualitative surveys of business owners, chief operating officers, policy makers, and investors. 


These insights will also help your customers overcome their fears. Actionable results findings in this study are indispensable guidelines for meeting all business priorities, including mission-critical priorities. After implementation, the results provide tangible benefits for business stakeholders and industry entities to drive their performance. 


The results are tailored according to the personal strategic framework. The research also illustrates some recent case studies about solving various problems faced by companies in the integration process. Strategic Framework This research enables companies and anyone interested in the market to develop a broad strategic framework. Given the current uncertainty caused by COVID-19, this has become more important than ever. The study considered negotiations to overcome some of the interruptions in the past and envisaged new interruptions to advance preparations."

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook


Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports